Utah Bill Will Establish Task Force to Research Medical Use of Psychedelics

Representative Brady Brammer recently filed a measure that would establish a task force to investigate whether psychedelic substances should be used as a treatment option for post-traumatic stress disorder and other mental health conditions. In an interview last week, the Utah representative stated that while he hadn’t explored psychedelics personally, he empathized with individuals who were struggling with mental illnesses.

While the measure in question, House Bill 167, doesn’t legalize psychedelic substances, it does request experts in the Huntsman Mental Health Institute and others involved in the psychedelic field to analyze research and the scientific evidence on psychedelics and give recommendations on how the substances can be administered safely on a prescription basis.

The measure is backed by Utah Patients Coalition, which got medical marijuana legalized in the state of Utah. The state legalized the use of medical cannabis for qualified patients in 2018, after voters in the state approved Proposition 2. Utah Patients Coalition’s medical director Kylee Shumway stated that there weren’t enough psychiatrists or mental health professionals to help individuals looking for assistance, despite the higher rates of anxiety and depression being recorded, noting that most drugs for these conditions weren’t effective.

Research on psychedelic substances in the treatment of mental health conditions has shown promise, with Johns Hopkins publishing various studies, which have demonstrated positive outcomes.

The measure has also received support from Steve Urquhart, a former state senator of Utah. In an interview, Urquhart stated that psychedelics impacted his life by changing how he saw and regarded himself, which allowed him to see others and love them more. The former Republican legislator formed the Divine Assembly, a church that uses psychedelic substances legally as part of its worship. Urquhart explained that he formed the church to allow individuals to have the freedom to worship with psychedelic substances, noting that his church was about connections, which psychedelics could help with. In addition to this, the former legislator stated that he was optimistic about the measure as he believed Utah’s state legislature would back HB167.

In his interview, Brammer maintained that his measure wouldn’t lead to the use of recreational psychedelics in the state, as that wasn’t his intention. He asserted that this wasn’t the slippery slope some legislators were concerned about when voters in Utah legalized medical marijuana use, adding that psychedelics were a different type of treatment and would probably need more medical supervision than the administration of medical marijuana, as is the case in the places where entities such as Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) legally run ketamine clinics.

NOTE TO INVESTORS: The latest news and updates relating to Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) are available in the company’s newsroom at https://ibn.fm/DELCF

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)

For more information please visit https://www.psychedelicnewswire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/Disclaimer

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com

PsychedelicNewsWire is part of the InvestorBrandNetwork.